Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Omalizumab, ATC R03DX05 (OBO) for the period 01.08.2024 - 31.07.2025 (plus extension option 1x12 months)

This tender with title Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Omalizumab, ATC R03DX05 (OBO) for the period 01.08.2024 - 31.07.2025 (plus extension option 1x12 months) has been published on Bidding Source portal dated 19 Jun 2024 for the country of Germany. It has been categorized on . For similar tenders you can see tenders mentioned below of this page.